Skip to main content

Table 1 Study schedule of KM110329 clinical trial (8 weeks)

From: KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial – study protocol

  Screening Treatment period
  Visit 1 Visit 2 Visit 3 Visit 4 Visit 5
(D − 7) (D 0) (D 7) (D 28) (D 56)
Informed consent     
Demographic characteristic eristic     
SCORAD index
Dermatology Life Quality Index  
Laboratory tests 1   
Test for chronic hepatitis 2     
Drug use history     
Concomitant medication
Pregnancy test
Medical/drug use history
Adverse event   
Compliance calculation   
Inclusion/exclusion criteria check     
  1. 1CBC (RBC, Hb, Hct, WBC, Platelet, ESR), Immunological tests (Eosinophil, IgE, IL-4, IL-5, IL-13), Liver function tests (AST, ALT), Renal function tests (BUN, Creatinine).
  2. 2Anti-HBs, HBsAg.